Search for: "Jon Gelman" Results 281 - 300 of 1,497
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Oct 2017, 12:08 pm by Jon Gelman
  For over 4 decades theLaw Offices of Jon L Gelman  1.973.696.7900  jon@gelmans.com  has been representing injured workers and their families who have suffered occupational accidents and illnesses. [read post]
12 Apr 2017, 6:08 am by Jon Gelman
 For over 4 decades the Law Offices of Jon L Gelman  1.973.696.7900  jon@gelmans.com  has been representing injured workers and their families who have suffered occupational accidents and illnesses. [read post]
26 Dec 2017, 10:23 am by Jon Gelman
" Gelman, Jon L, Workers Compensation Law, 38 NJPRAC 28.1 fn 2 (Thomson-Reuters 2017).Dana Munch v. [read post]
4 Apr 2019, 2:31 pm by Jon L. Gelman
Gelman, Jon L, Workers’ Compensation Law, Pulmonary Disease Generally,38 NJPRAC 9.6 (Thomson-Reuters 2019). [read post]
18 Jan 2022, 3:36 am by Jon L. Gelman
See the guidance released on December 28, 2021, for additional information.Recommended Citation: Gelman, Jon L. [read post]
17 Jul 2021, 5:00 am by Jon L. Gelman
For over 4 decades the Law Offices of Jon L Gelman 1.973.696.7900 jon@gelmans.com has been representing injured workers and their families who have suffered occupational accidents and illnesses.Jon L. [read post]
1 Apr 2019, 12:05 pm by Jon L. Gelman
Gelman, Jon L, Workers’ Compensation Law, 38 NJPRAC 7.7, “Lent employees and dual employment. [read post]
28 Jan 2022, 6:09 pm by Jon L. Gelman
Superior Court of New Jersey, Appellate Division.Recommended Citation: Gelman, Jon L. [read post]
8 Oct 2022, 2:05 am by Jon L. Gelman
It indicates the need for specific interventions in the ongoing multicountry outbreak.Recommended Citation: Gelman, Jon L. [read post]
28 Feb 2022, 3:38 am by Jon L. Gelman
A-3258-20, 2022 WL 497657, Decided Feb. 18, 2022.Recommended Citation: Gelman, Jon L. [read post]
12 Jul 2022, 3:56 am by Jon L. Gelman
The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.It is made available under a CC-BY-NC-ND 4.0 International license .Recommended Citation: Gelman, Jon L. [read post]